2612 related items for PubMed ID: 17825690
1. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[Abstract] [Full Text] [Related]
3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
4. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM, Boulet LP, Follows RM.
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[Abstract] [Full Text] [Related]
5. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M, Zachgo W, von Berg A, Kamin W, Stern-Sträter C, Steinkamp G, VIAPAED Study Group.
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[Abstract] [Full Text] [Related]
6. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[Abstract] [Full Text] [Related]
7. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[Abstract] [Full Text] [Related]
8. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K, Noonan M, Silkoff PE, Uryniak T.
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[Abstract] [Full Text] [Related]
9. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
You-Ning L, Humphries M, Du X, Wang L, Jiang J.
Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
[Abstract] [Full Text] [Related]
10. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
Malone R, LaForce C, Nimmagadda S, Schoaf L, House K, Ellsworth A, Dorinsky P.
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):66-71. PubMed ID: 16095144
[Abstract] [Full Text] [Related]
11. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
J Asthma; 2007 Jul; 44(6):437-41. PubMed ID: 17654129
[Abstract] [Full Text] [Related]
12. Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.
Renzi PM, Howard LA, Ortega HG, Ahmad FF, Chapman KR.
Respir Med; 2010 Apr; 104(4):510-7. PubMed ID: 19944581
[Abstract] [Full Text] [Related]
13. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE, Noonan MJ.
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[Abstract] [Full Text] [Related]
14. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[Abstract] [Full Text] [Related]
15. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
[Abstract] [Full Text] [Related]
16. Salmeterol xinafoate in children on high dose inhaled steroids.
Russell G, Williams DA, Weller P, Price JF.
Ann Allergy Asthma Immunol; 1995 Nov 29; 75(5):423-8. PubMed ID: 7583864
[Abstract] [Full Text] [Related]
17. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.
Clin Ther; 2007 Feb 29; 29(2):261-78. PubMed ID: 17472819
[Abstract] [Full Text] [Related]
18. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
Boonsawat W, Goryachkina L, Jacques L, Frith L.
Clin Drug Investig; 2008 Feb 29; 28(2):101-11. PubMed ID: 18211118
[Abstract] [Full Text] [Related]
19. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
Lundbäck B, Rönmark E, Lindberg A, Jonsson AC, Larsson LG, Pétavy F, James M.
Respir Med; 2006 Jan 29; 100(1):2-10. PubMed ID: 16243498
[Abstract] [Full Text] [Related]
20. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
Respir Med; 2008 May 29; 102(5):665-73. PubMed ID: 18328683
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
